Microba Life Sciences Limited Share Price
Equities
MAP
AU0000209868
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 AUD | -2.70% | 0.00% | 0.00% |
23/04 | Microba's Revenue Climbs 297% in Fiscal Q3 | MT |
10/04 | Microba Life Sciences Secures AU$6 Million Tax Rebate for Fiscal Year 2023; Shares Fall 5% | MT |
Sales 2024 * | 11.81M 7.8M 651M | Sales 2025 * | 17.97M 11.87M 991M | Capitalization | 80.61M 53.27M 4.44B |
---|---|---|---|---|---|
Net income 2024 * | -17M -11.23M -937M | Net income 2025 * | -16M -10.57M -882M | EV / Sales 2024 * | 5.09 x |
Net cash position 2024 * | 20.45M 13.51M 1.13B | Net cash position 2025 * | 17.07M 11.28M 941M | EV / Sales 2025 * | 3.54 x |
P/E ratio 2024 * |
-4.62
x | P/E ratio 2025 * |
-4.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 57.75% |
1 day | -2.70% | ||
Current month | -2.70% | ||
1 month | -14.29% | ||
3 months | +2.86% | ||
6 months | -21.74% |
Managers | Title | Age | Since |
---|---|---|---|
Luke Reid
CEO | Chief Executive Officer | - | - |
James Heath
DFI | Director of Finance/CFO | - | - |
Yao Liu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Capone
BRD | Director/Board Member | 61 | 18/21/18 |
Director/Board Member | - | 08/22/08 | |
Hyung-Tae Kim
BRD | Director/Board Member | 61 | - |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 0.18 | -2.70% | 14,712 |
02/24/02 | 0.185 | 0.00% | 16,986 |
30/24/30 | 0.185 | 0.00% | 1,580 |
29/24/29 | 0.185 | +2.78% | 30,151 |
26/24/26 | 0.18 | +12.50% | 344,355 |
Delayed Quote Australian S.E., May 03, 2024 at 08:47 am IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 53.31M | |
-18.58% | 8.3B | |
+47.25% | 3.78B | |
-8.58% | 2.47B | |
-38.71% | 2.46B | |
-10.06% | 2.31B | |
-5.44% | 1.95B | |
-17.79% | 1.59B | |
-40.78% | 1.21B | |
+6.69% | 1.1B |
- Stock Market
- Equities
- MAP Stock